LS Investment Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
TSW
ICOM
GACM
LS Investment Advisors's ANIP Position: Q3 2020 in Review
LS Investment Advisors sold out of ANI Pharmaceuticals (ANIP) in Q3 2020, closing a stake of 2,401 shares — an estimated $78K sold.
LS Investment Advisors first reported a position in ANIP in Q2 2015 and held it in 21 quarters. The position peaked at $148K in Q4 2019. 116 funds tracked by Wall St. Rank hold ANIP as of Q3 2020.
- LS Investment Advisors reported no remaining ANI Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
- LS Investment Advisors sold 2,401 ANI Pharmaceuticals shares in Q3 2020, an estimated $78K.
- LS Investment Advisors first reported a position in ANI Pharmaceuticals in Q2 2015 and held it in 21 quarters.
- LS Investment Advisors's ANI Pharmaceuticals position peaked at $148K in Q4 2019.
- 116 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2020.
Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.